3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Buy
77
HALO Quote, Financials, Valuation and Earnings
Last price:
$63.18
Seasonality move
:
3.37%
Day range:
$62.60 - $64.07
52-week range:
$37.73 - $66.00
Dividend yield:
0%
P/E ratio:
18.60x
P/S ratio:
8.13x
P/B ratio:
21.60x
Volume:
1.6M
Avg. volume:
1.5M
1-year change:
56.86%
Market cap:
$7.9B
Revenue:
$1B
EPS (TTM):
$3.43
Halozyme Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
HALO
Halozyme Therapeutics
|
05/07/2024 | 10-Q | 10-Q filing on 05/07/2024 | View Form |
|
HALO
Halozyme Therapeutics
|
11/06/2023 | 10-Q | 10-Q filing on 11/06/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
08/08/2023 | 10-Q | 10-Q filing on 08/08/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2023 | 10-Q | 10-Q filing on 05/09/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
11/08/2022 | 10-Q | 10-Q filing on 11/08/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2022 | 10-Q | 10-Q filing on 08/09/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2022 | 10-Q | 10-Q filing on 05/10/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
11/02/2021 | 10-Q | 10-Q filing on 11/02/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2021 | 10-Q | 10-Q filing on 08/09/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2021 | 10-Q | 10-Q filing on 05/10/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
11/02/2020 | 10-Q | 10-Q filing on 11/02/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
08/10/2020 | 10-Q | 10-Q filing on 08/10/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
05/11/2020 | 10-Q | 10-Q filing on 05/11/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
02/24/2020 | 10-K | 10-K filing on 02/24/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
11/12/2019 | 10-Q | 10-Q filing on 11/12/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
08/06/2019 | 10-Q | 10-Q filing on 08/06/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
05/07/2019 | 10-Q | 10-Q filing on 05/07/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
02/21/2019 | 10-K | 10-K filing on 02/21/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
11/06/2018 | 10-Q | 10-Q filing on 11/06/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
02/20/2018 | 10-K | 10-K filing on 02/20/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
11/07/2017 | 10-Q | 10-Q filing on 11/07/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
08/08/2017 | 10-Q | 10-Q filing on 08/08/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2017 | 10-Q | 10-Q filing on 05/09/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
02/28/2017 | 10-K | 10-K filing on 02/28/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
11/07/2016 | 10-Q | 10-Q filing on 11/07/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2016 | 10-Q | 10-Q filing on 08/09/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2016 | 10-Q | 10-Q filing on 05/09/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
02/29/2016 | 10-K | 10-K filing on 02/29/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
11/09/2015 | 10-Q | 10-Q filing on 11/09/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
08/11/2015 | 10-Q | 10-Q filing on 08/11/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
08/10/2015 | 10-Q | 10-Q filing on 08/10/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
05/11/2015 | 10-Q | 10-Q filing on 05/11/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 16.57% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 6.7% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 4.96% over the past day.
